Search by Drug Name or NDC

    NDC 45802-0433-21 dextromethorphan polistirex extended release 30 mg/5mL Details

    dextromethorphan polistirex extended release 30 mg/5mL

    dextromethorphan polistirex extended release is a ORAL SUSPENSION in the HUMAN OTC DRUG category. It is labeled and distributed by Padagis Israel Pharmaceuticals Ltd. The primary component is DEXTROMETHORPHAN HYDROBROMIDE.

    Product Information

    NDC 45802-0433
    Product ID 45802-433_d58d9232-d3e8-46fa-adac-a5ff81d79c7b
    Associated GPIs 4310203060G110
    GCN Sequence Number 004630
    GCN Sequence Number Description dextromethorphan polistirex SUS ER 12H 30 MG/5 ML ORAL
    HIC3 H6C
    HIC3 Description ANTITUSSIVES, NON-OPIOID
    GCN 17802
    HICL Sequence Number 010295
    HICL Sequence Number Description DEXTROMETHORPHAN POLISTIREX
    Brand/Generic Generic
    Proprietary Name dextromethorphan polistirex extended release
    Proprietary Name Suffix n/a
    Non-Proprietary Name dextromethorphan polistirex
    Product Type HUMAN OTC DRUG
    Dosage Form SUSPENSION
    Route ORAL
    Active Ingredient Strength 30
    Active Ingredient Units mg/5mL
    Substance Name DEXTROMETHORPHAN HYDROBROMIDE
    Labeler Name Padagis Israel Pharmaceuticals Ltd
    Pharmaceutical Class Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA091135
    Listing Certified Through 2024-12-31

    Package

    NDC 45802-0433-21 (45802043321)

    NDC Package Code 45802-433-21
    Billing NDC 45802043321
    Package 1 BOTTLE in 1 CARTON (45802-433-21) / 89 mL in 1 BOTTLE
    Marketing Start Date 2012-09-10
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.06416
    Pricing Unit ML
    Effective Date 2024-02-21
    NDC Description DEXTROMETHORPHAN ER 30 MG/5 ML
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL 7a6b68eb-8fe0-447d-aed7-28432c45b58c Details

    Revised: 11/2021